These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 32543135)
1. [Effects of shRNA on Cisplatin-resistant Non-small Cell Lung Cancer Cell A549 via Silencing He L; Du ZD; Wang Y; Meng RQ; Zhao WW Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):312-319. PubMed ID: 32543135 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells. Yu G; Zhong N; Chen G; Huang B; Wu S Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915 [TBL] [Abstract][Full Text] [Related]
3. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line. Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998 [TBL] [Abstract][Full Text] [Related]
5. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
6. [ Ma J; Chen SJ; Qin Y; Zhang YY; Sun XF Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):430-437. PubMed ID: 34018361 [TBL] [Abstract][Full Text] [Related]
7. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression. Ju ZS; Sun B; Bao D; Zhang XF Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788 [TBL] [Abstract][Full Text] [Related]
8. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
9. [Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis]. Zhou SK; Gao F; Zhong ZS; Yao H Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):944-951. PubMed ID: 33036509 [No Abstract] [Full Text] [Related]
10. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin. Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235 [TBL] [Abstract][Full Text] [Related]
11. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway. Cai Y; Dong ZY; Wang JY Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323 [TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells. Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026 [TBL] [Abstract][Full Text] [Related]
13. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3. Qi MM; Ge F; Chen XJ; Tang C; Ma J Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375 [TBL] [Abstract][Full Text] [Related]
14. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis. Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768 [TBL] [Abstract][Full Text] [Related]
15. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin. Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580 [TBL] [Abstract][Full Text] [Related]
16. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy. Ma J; Wu K; Liu K; Miao R Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314 [TBL] [Abstract][Full Text] [Related]
17. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
18. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile]. Hu S; Hu CP; Liang CH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of human mitochondria-targeted MPG recombinant on proliferation of human non-small cell lung cancer multidrug-resistant cell line A549/DDP]. Yu SC; Qian GS; Li YY; Lu WZ; Li J; Huang GJ Ai Zheng; 2006 Apr; 25(4):421-6. PubMed ID: 16613673 [TBL] [Abstract][Full Text] [Related]
20. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain]. Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]